Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Operating activities:
Net income	$ 10,646	$ 592
Loss from discontinued operations	1,313	4,921
Income from continuing operations	11,959	5,513
Adjustments to reconcile net income to net cash provided by operating activities:
Stock-based compensation expense	7,455	6,145
Amortization and impairments to operating lease assets	8,765	19,708
Depreciation	9,778	10,805
Amortization of intangible assets	10,677	18,528
Amortization and write-off of debt discount and issuance costs	1,155	4,227
Provision for bad debts	10,226	5,991
Deferred income taxes	2,165	2,629
Loss on disposals, accelerated depreciation, and impairments to property and equipment	38	3,483
Gain on extinguishment of debt	0	(71)
Loss on investments	447	901
Changes in assets and liabilities:
Accounts receivable	(50,116)	(33,219)
Prepaid expenses and other current assets	(5,532)	(2,483)
Accounts payable	(2,870)	8,711
Accrued payroll and benefits	(8,882)	(12,743)
Accrued liabilities	13,770	(9,010)
Deferred revenue	98,658	82,688
Operating lease liabilities	(10,053)	(12,921)
Other assets and liabilities	(6,914)	(7,406)
Net cash provided by operating activities-continuing operations	90,726	91,476
Net cash provided by (used in) operating activities-discontinued operations	8,959	(130)
Net cash provided by operating activities	99,685	91,346
Investing activities:
Capital expenditures	(15,046)	(5,551)
Proceeds from sale of marketable securities	400	356
Purchases of marketable securities	(300)	(308)
Net cash used in investing activities-continuing operations	(14,946)	(5,503)
Payment for working capital adjustment for sale of business	0	(811)
Net cash used in investing activities	(14,946)	(6,314)
Financing activities:
Proceeds from exercise of stock options	550	1,241
Employee taxes paid on withholding shares	(5,651)	(3,486)
Proceeds from stock issued under Colleague Stock Purchase Plan	190	132
Repurchases of common stock for treasury	(90,477)	0
Repayments of long-term debt	0	(100,861)
Net cash used in financing activities	(95,388)	(102,974)
Net decrease in cash, cash equivalents and restricted cash	(10,649)	(17,942)
Cash, cash equivalents and restricted cash at beginning of period	275,075	347,937
Cash, cash equivalents and restricted cash at end of period	264,426	329,995
Non-cash investing and financing activities:
Accrued capital expenditures	9,217	4,713
Accrued liability for repurchases of common stock	3,600	0
Accrued excise tax on share repurchases	$ 1,928	$ 0